newsfilter
← Latest News
GlobeNewswire·

Hepion Pharmaceuticals, Inc. Announces Reverse Stock Split

EDISON, N.J., May 10, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for